June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
The Ocular Pain Assessment Survey and In Vivo Confocal Microscopy as Valuable Tools in the Diagnosis and Management of Patients with Corneal Neuropathic Pain
Author Affiliations & Notes
  • Maria J Lopez
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Alessandro Abbouda
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Nicholas Pondelis
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Bijan Khaksari
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Arsia Jamali
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • zeina salem
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Pedram Hamrah
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Maria Lopez, None; Alessandro Abbouda, None; Nicholas Pondelis, None; Bijan Khaksari, None; Arsia Jamali, None; zeina salem, None; Pedram Hamrah, Allergan (C), Allergan (F), Dompe (C), GlaxoSmithKline (C), GlaxoSmithKline (F), Shire (C), Shire (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1013. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Maria J Lopez, Alessandro Abbouda, Nicholas Pondelis, Bijan Khaksari, Arsia Jamali, zeina salem, Pedram Hamrah; The Ocular Pain Assessment Survey and In Vivo Confocal Microscopy as Valuable Tools in the Diagnosis and Management of Patients with Corneal Neuropathic Pain. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1013.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Quality of life (QOL) in patients with corneal neuropathic pain (CNP) can be greatly diminished due to the high impact of this condition on patients' daily activities. Diagnosis and management of these patients are challenging due to the lack of clinical signs on slit-lamp examination. This study was designed to assess new tools for the diagnosis of patients with CNP utilizing in vivo confocal microscopy (IVCM) and a novel quantitative pain questionnaire, the Ocular Pain Assessment Survey (OPAS) and the utility of the combination of these in the management of patients with CNP.

Methods : This is a cross-sectional, single-center study, including 18 patients with the diagnosis of CNP who had completed the OPAS questionnaire. IVCM was performed for the central cornea of all patients. Two masked observers analyzed three representative IVCM images of the subbasal corneal nerve layer for the density of microneuromas (injured nerves that develop enlarged terminal sprouts), nerve density, dendritiform cell (DC) density and morphology (DC field). IVCM data were correlated with results of OPAS questionnaire utilizing Pearson’s correlation test. A p-value <0.05 was considered statistically significant.

Results : The mean age of patients was 54.7±14.8 years (Male/female ratio: 5/13). On IVCM, 100% of patients presented microneuromas (density 6.35±0.66 neuromas/mm2). This presence of microneuromas correlated positively with the severity of ocular pain at the day of the visit and during the last two weeks (R=0.530 and 0.501, p=0.02 and 0.04 respectively), and eye pain affecting overall QOL (R=0.566, p=0.02). DC field on IVCM (mean 185.5±123.2 µm2), a sign of immune activation showed significant correlation with eye pain during the last two weeks (R=0.523, p=0.03). Nerve density (mean 11.37±6.93 mm/mm2) correlated with the presence of associated factors such as redness, burning, sensitivity to light and tearing (R=0.567, p=0.02).

Conclusions : The OPAS questionnaire provides a novel tool in the quantitative assessment of CNP patients' symptoms. Microneuromas on IVCM may potentially serve as a diagnostic marker for CNP. The combination of IVCM for assessment of signs and OPAS for assessment of symptoms s may serve as valuable tools in the management of patients with CNP.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×